Xencor is a biopharmaceutical company that specializes in the engineering of monoclonal antibodies to create new therapeutics for the treatment of autoimmune diseases, allergic conditions, and cancer. Founded in 1997, Xencor has developed a proprietary protein engineering technology platform that has enabled the creation of novel antibody candidates with enhanced potency, specificity, and half-life. The company's innovative approach to drug development has positioned it as a leader in the field of antibody engineering, with a robust pipeline of potential treatments in various stages of clinical development.

Get a job referral to Xencor

Description

Jobs

About

Financials

Referrals